HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kleine, P. Articles by Liebold, A. Search for Related Content PubMed PubMed Citation Articles by Kleine, P. Articles by Liebold, A.

Eur J Cardiothorac Surg 1999;15:525-527
© 1999 Elsevier Science NL

Multicenter results of TADpole^TM heart wire system used to treat postoperative atrial fibrillation¹

European Multicenter Study Group, Department for Cardiovascular Surgery, Herz-Kreislauf-Klinik Bevensen, Römstedter Str. 25, 29549 Bad Bevensen, Germany

Received 23 September 1998; received in revised form 31 December 1998; accepted 13 January 1999.

Corresponding author.

Objective: Postoperative atrial fibrillation (AF) affects 20–30% of patients undergoing open-heart surgery, delays mobilization and impairs hemodynamics. Implantation of TADpole^TM Heart Wires offers a new method of applying internal low-energy-shocks to terminate AF. The safety and efficacy of the TADpole^TM system to treat postoperative AF was evaluated in this multicenter trial. Methods: Two atrial wires, configured with a highly flexible 11.5 cm distal shocking and a 0.5 cm proximal pacing electrode were sutured onto the right and left atrium. Upon detection of AF, R-wave synchronized low-energy-shocks were administered via an energy attenuating External Defibrillator Interface Module or ICD programmer. Results: A total of 296 patients (65±9.2 years, 74.7% male) have been enrolled to date in six European centers. The wire placement time was 4.2±2.2 min, 65 patients had a total of 83 episodes of AF treated by the TADpole^TM Heart Wire system with a conversion rate of 88.5% (approximate energy of 6±2 J), early recurrence of AF was observed in ten patients (12.8%). No clinical complications were reported. The shocks were well tolerated with slight sedation. The ease of withdrawal was 2.3±1.2 on a graded scale of 0 (easy) to 10 (difficult). Conclusions: These multicenter results indicate that postoperative atrial cardioversion using TADpole^TM Heart Wires is both safe and efficient. It is expected that hospital length of stay and its associated economic impact can be reduced with this therapy.

Key Words: Atrial fibrillation • Cardioversion • Open heart surgery

This article has been cited by other articles:

				K. Iino, N. Yui, T. Ooya, R. Kawabata, S. Tomita, and G. Watanabe Successful low-energy cardioversion using a novel biodegradable gel pad: Feasibility of treating postoperative atrial fibrillation in animals. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1519 - 1525. [Abstract] [Full Text] [PDF]

				A. A. Vaporciyan, A. M. Correa, D. C. Rice, J. A. Roth, W. R. Smythe, S. G. Swisher, G. L. Walsh, and J. B. Putnam Jr Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 779 - 786. [Abstract] [Full Text] [PDF]